Marqeta, Inc. (MQ) stock
Close on Nov 17, 2026Market cap $1.79BP/E 171.8Yield –
Earnings
Marqeta's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Marqeta's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 23, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 3, 2026after the close | $176.00M | +8.0% | $1.09 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 4, 2026after the close | $176.00M | +17.3% | $0.07 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 5, 2026after the close | $166.00M | +19.4% | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 24, 2026after the close | $172.00M | +26.5% | $0.00 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 5, 2025after the close | $163.00M | +27.3% | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 6, 2025after the close | $150.00M | +20.0% | $0.00 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 7, 2025after the close | $139.00M | +17.8% | -$0.02 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 26, 2025after the close | $136.00M | +14.3% | -$0.05 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 4, 2024after the close | $128.00M | +17.4% | -$0.06 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 7, 2024after the close | $125.00M | -45.9% | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 7, 2024after the close | $118.00M | -45.6% | -$0.07 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 28, 2024after the close | $119.00M | -41.7% | -$0.08 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 7, 2023after the close | $109.00M | -43.2% | -$0.10 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 8, 2023after the close | $231.00M | +23.5% | -$0.11 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 9, 2023after the close | $217.00M | +30.7% | -$0.13 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 28, 2023after the close | $204.00M | – | -$0.05 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 9, 2022after the close | $192.00M | +45.5% | -$0.10 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 10, 2022after the close | $187.00M | – | -$0.08 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 11, 2022after the close | $166.00M | – | -$0.11 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 9, 2022after the close | – | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 10, 2021after the close | $132.00M | – | -$0.08 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 11, 2021after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Marqeta's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net Revenue GrowthGAAP | Q4 FY2026 | +3% – +5% | – | New | Nov 3, 2026 |
| Gross Profit GrowthGAAP | Q4 FY2026 | +5% – +7% | – | New | Nov 3, 2026 |
| Net Revenue GrowthGAAP | FY2026 | +11% – +12% | – | New | Nov 3, 2026 |
| Net Revenue Growth | FY2026 | +12% – +13% | +12% – +14% | Lowered | Aug 4, 2026 |
| Gross Profit GrowthGAAP | FY2026 | +11% – +12% | – | New | Nov 3, 2026 |
| Gross Profit Growth | FY2026 | +11% – +12% | +10% – +12% | Raised | Aug 4, 2026 |
Guidance vs results
The last range Marqeta gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | Revenue growth | +6% – +8% | +7.98% | Within range |
| Q1 FY2026 | Revenue growth | +17% – +19% | +19.42% | Above range |
| Q4 FY2025 | Revenue growth | +22% – +24% | +26.47% | Above range |
| Q3 FY2025 | Revenue growth | +15% – +17% | +27.34% | Above range |
| Q2 FY2025 | Revenue growth | +11% – +13% | +20% | Above range |
| Q1 FY2025 | Revenue growth | +14% – +16% | +17.8% | Above range |
| Q4 FY2024 | Revenue growth | +10% – +12% | +14.29% | Above range |
| Q2 FY2023 | Revenue growth | +17% – +19% | +23.53% | Above range |
| Q1 FY2023 | Revenue growth | +26% – +28% | +30.72% | Above range |
| Q3 FY2022 | Revenue growth | +36% – +38% | +45.45% | Above range |
Guidance history
Every forecast Marqeta put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 3, 2026 | Gross Profit Growth | Q4 FY2026 | +5% – +7% | New |
| Nov 3, 2026 | Gross Profit Growth | FY2026 | +11% – +12% | New |
| Nov 3, 2026 | Net Revenue Growth | Q4 FY2026 | +3% – +5% | New |
| Nov 3, 2026 | Net Revenue Growth | FY2026 | +11% – +12% | New |
| Aug 4, 2026 | Adjusted EBITDA Growth | Q3 FY2026 | +20% – +25% | New |
| Aug 4, 2026 | Gross Profit Growth | FY2026 | +11% – +12% | Raised |
| Aug 4, 2026 | Gross Profit Growth | Q3 FY2026 | +5% – +7% | New |
| Aug 4, 2026 | Net Revenue Growth | FY2026 | +12% – +13% | Lowered |
| Aug 4, 2026 | Net Revenue Growth | Q3 FY2026 | +6% – +8% | New |
| Feb 24, 2026 | Adjusted EBITDA Growth | Q1 FY2026 | +45% – +50% | New |
| Feb 24, 2026 | Gross Profit Growth | FY2026 | +10% – +12% | New |
| Feb 24, 2026 | Gross Profit Growth | Q1 FY2026 | +17% – +19% | New |
| Feb 24, 2026 | Net Revenue Growth | FY2026 | +12% – +14% | New |
| Feb 24, 2026 | Net Revenue Growth | Q1 FY2026 | +17% – +19% | New |
| Nov 5, 2025 | Adjusted EBITDA Margin | Q4 FY2025 | 15% – 16% | New |
| Nov 5, 2025 | Gross Profit Growth | Q4 FY2025 | +17% – +19% | New |
| Nov 5, 2025 | Net Revenue Growth | Q4 FY2025 | +22% – +24% | New |
| Aug 6, 2025 | Adjusted EBITDA Margin | Q3 FY2025 | 12% – 13% | New |
| Aug 6, 2025 | Gross Profit Growth | Q3 FY2025 | +15% – +17% | New |
| Aug 6, 2025 | Net Revenue Growth | Q3 FY2025 | +15% – +17% | New |
| May 7, 2025 | Adjusted EBITDA Margin | Q2 FY2025 | 10% – 11% | New |
| May 7, 2025 | Adjusted EBITDA Margin | FY2025 | 10% – 11% | Raised |
| May 7, 2025 | Gross Profit Growth | Q2 FY2025 | +23% – +25% | New |
| May 7, 2025 | Gross Profit Growth | FY2025 | +14% – +16% | Reaffirmed |
| May 7, 2025 | Net Revenue Growth | Q2 FY2025 | +11% – +13% | New |
| May 7, 2025 | Net Revenue Growth | FY2025 | +13% – +15% | Lowered |
| Feb 26, 2025 | Adjusted EBITDA Margin | Q1 FY2025 | 10% – 11% | New |
| Feb 26, 2025 | Adjusted EBITDA Margin | FY2025 | 9% – 10% | New |
| Feb 26, 2025 | Gross Profit Growth | Q1 FY2025 | +11% – +13% | New |
| Feb 26, 2025 | Gross Profit Growth | FY2025 | +14% – +16% | New |
| Feb 26, 2025 | Net Revenue Growth | Q1 FY2025 | +14% – +16% | New |
| Feb 26, 2025 | Net Revenue Growth | FY2025 | +16% – +18% | New |
| Nov 4, 2024 | Adjusted EBITDA Margin | Q4 FY2024 | 5% – 7% | New |
| Nov 4, 2024 | Gross Profit Growth | Q4 FY2024 | +13% – +15% | New |
| Nov 4, 2024 | Net Revenue Growth | Q4 FY2024 | +10% – +12% | New |
| May 9, 2023 | Adjusted EBITDA Margin | Q2 FY2023 | -6% – -4% | New |
| May 9, 2023 | Gross Profit Growth | Q2 FY2023 | +1% – +3% | New |
| May 9, 2023 | Net Revenue Growth | Q2 FY2023 | +17% – +19% | New |
| Feb 28, 2023 | Adjusted EBITDA Margin (1) | Q1 FY2023 | -6% – -5% | New |
| Feb 28, 2023 | Gross Profit Growth | Q1 FY2023 | +14% – +16% | New |
| Feb 28, 2023 | Net Revenue Growth | Q1 FY2023 | +26% – +28% | New |
| Nov 9, 2022 | Adjusted EBITDA Margin (1) | Q4 FY2022 | -6% – -5% | New |
| Nov 9, 2022 | Gross Profit Margin | Q4 FY2022 | 42% – 43% | New |
| Nov 9, 2022 | Net Revenue Growth | Q4 FY2022 | +29% – +31% | New |
| Aug 10, 2022 | Adjusted EBITDA Margin | Q3 FY2022 | -9% – -8% | New |
| Aug 10, 2022 | Gross Profit Margin | Q3 FY2022 | 43% – 44% | New |
| Aug 10, 2022 | Net Revenue Growth | Q3 FY2022 | +36% – +38% | New |
| May 11, 2022 | Adjusted EBITDA Margin | Q2 FY2022 | -11% – -10% | New |
| May 11, 2022 | Gross Profit Margin | Q2 FY2022 | 40% – 41% | New |
| May 11, 2022 | Net Revenue Growth | Q2 FY2022 | +46% – +48% | New |
| Nov 10, 2021 | Adjusted EBITDA | Q4 FY2021 | -$10.00M – -$7.00M | New |
| Nov 10, 2021 | Net revenue | Q4 FY2021 | $134.00M – $139.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Marqeta filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?